Contact this trialFirst, we need to learn more about you.
Lipid-lowering Agent
Obicetrapib + Ezetimibe for Coronary Artery Disease
Recruiting1 awardPhase 3
Hialeah, Florida
This trial is testing a new medication combination in adults with high-risk cardiovascular disease who are not responding well to their current treatment. The study aims to see how the new medication affects coronary plaque and inflammation using
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service